ArticleBritish journal of cancer2026
Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.
Ziqian Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it